Company: VREOF
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001558370-25-002130
Chunk: 0

Company: Vireo Growth Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 10
Chunk 0
---
Item 10.Directors, Executive Officers and Corporate Governance

The following table sets forth information regarding each director and executive officer of Vireo.  The term of office of each of the five current directors will end at the conclusion of the 2025 Annual Meeting of Shareholders. Elected directors serve until the next annual general meeting of the shareholders or until their successors are elected or appointed. A brief biography of each person who serves as a director or executive officer follows the table.

​

Name    Age*    PositionDr. Kyle E. Kingsley50Co-Executive Chair of the BoardJohn Mazarakis​48​Co-Executive Chair of the Board and Chief Executive OfficerRoss M. Hussey​47​DirectorVictor E. Mancebo​41​DirectorJudd T. Nordquist​55​DirectorTyson Macdonald​50​Chief Financial OfficerAmber H. Shimpa46President of Goodness Growth and Chief Executive Officer of Vireo Health of Minnesota

​

*As of the date of filing of this Form 10-K.

Dr. Kyle E. Kingsley is a board-certified emergency medicine physician and founder, Executive Chairman and a director of Vireo. Dr. Kingsley served as Chief Executive Officer and Chairman of the Board of Vireo from July 2014 to February 2023. Dr. Kingsley has served as a director of Vireo (and its predecessors Goodness Growth Holdings Inc./Vireo Health International, Inc./Vireo Health, Inc./Minnesota Medical Solutions LLC) since July 2014, and he was appointed Executive Chairman of Vireo in February 2023. Dr.  Kingsley has expansive experience in starting medical cannabis companies in well-regulated, limited-license states with narrow timelines for implementation. Dr.  Kingsley has been involved with all aspects of medical cannabis implementation, from horticulture and manufacturing to finance and policy. Dr.  Kingsley’s primary goal is to build mainstream, cannabis-based, alternatives to opioids, alcohol, and tobacco. Dr.  Kingsley’s prior experience with opioid pain medications and alcohol in the emergency department setting was a major reason for his desire to build a science-focused cannabis company. Simultaneously with his emergency medicine staffing responsibilities,